−22.2
Lisata Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−21.2
FY23:
−20.0
FY24:
−19.4
FY25:
−15.9
Change from FY21 to FY25
millions USD
FY21:
−54.9
FY22:
28.9
FY23:
10.1
FY24:
13.2
FY25:
15.1
Change from FY21 to FY25
millions USD
FY21:
85.3
FY22:
−0.22
FY23:
0.39
FY24:
−0.21
FY25:
0.60
millions USD
FY21:
8.14
FY22:
7.51
FY23:
−9.56
FY24:
−6.38
FY25:
−0.25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−22.3
FY22:
−21.5
FY23:
−20.0
FY24:
−19.4
FY25:
−16.0
All amounts in millions USD